The biotech company’s IT chief sees the capabilities management model as key to expanding Illumina’s business focus from research and manufacturing to clinical-based genomic health.
Another local company gets a stock delisting warning for a lagging share price, plus a new CFO at a local REIT, a bank director resigns and there's a new board member at Dominion.
/PRNewswire/ Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the first quarter of fiscal year 2022, which include consolidated.
Cybersecurity in an evolving work environment - Minneapolis / St Paul Business Journal bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.